FDA Approves Vascepa (icosapent ethyl) to Reduce Cardiovascular Risk

Article Link: FDA Approves Vascepa (icosapent ethyl) to Reduce Cardiovascular Risk

DUBLIN, Ireland and BRIDGEWATER, N.J., Dec. 13, 2019 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ: AMRN) today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication and label expansion for…

Source: FDA New Drug Approvals